Jonathan E. Lim, M.D., is a distinguished medical professional and entrepreneur, currently serving as Chairman, Chief Executive Officer, and Co-Founder of ERASCA INC., a biopharmaceutical company focused on developing novel therapies for cancer. Dr. Lim earned his medical degree from the University of California, San Diego School of Medicine and completed his residency in internal medicine at the University of California, Los Angeles. He further honed his expertise through a fellowship in medical oncology at the National Cancer Institute, where he gained invaluable experience in cancer research and treatment. Throughout his career, Dr. Lim has been recognized for his contributions to the field of oncology and his leadership in the biotechnology industry. Prior to founding ERASCA, he held various leadership positions at other biopharmaceutical companies, including serving as President and CEO of IDEAYA Biosciences, where he played a pivotal role in advancing the company's pipeline of targeted cancer therapies. Dr. Lim's extensive experience in drug development, coupled with his deep understanding of cancer biology, has been instrumental in guiding ERASCA's mission to bring innovative treatments to patients with high unmet medical needs. As Chairman, CEO, and Co-Founder of ERASCA, Dr. Lim is responsible for overseeing the company's overall strategy, operations, and growth. Under his leadership, ERASCA has made significant progress in advancing its portfolio of precision oncology programs, with a focus on targeting the RAS/MAPK pathway, a key driver of many cancers. Dr. Lim's vision and dedication to improving patient outcomes have been crucial in positioning ERASCA as a leader in the development of next-generation cancer therapies.